Skip to Content

Cabozantinib Pregnancy and Breastfeeding Warnings

Cabozantinib is also known as: Cabometyx, Cometriq

Cabozantinib Pregnancy Warnings

Animal studies have revealed embryofetal toxicity and teratogenic effects. Data from animals also showed male and female fertility impairment. There are no controlled data in human pregnancy, and the effect of this drug on human fertility is unknown. US FDA pregnancy category D: There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if clearly needed. US FDA pregnancy category: D Comments: -All patients and their partners should be encouraged to use effective contraception during treatment and for at least 4 months after treatment completion, and advised to consider fertility preservation before treatment. -Patients using contraceptive steroids should use an additional contraceptive method, such as a barrier method, since the effect of this drug on contraceptive steroids has not been investigated and unchanged contraceptive effect may not be guaranteed.

See references

Cabozantinib Breastfeeding Warnings

Breastfeeding is not recommended during use of this drug, and for at least 4 months after treatment completion. Excreted into human milk: Unknown Excreted into animal milk: Data not available Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Cometriq (cabozantinib)." Exelixis Inc, S San Francisco, CA.

References for breastfeeding information

  1. "Product Information. Cometriq (cabozantinib)." Exelixis Inc, S San Francisco, CA.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.